Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice (Q40737184)

23 September 2017

Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice (English)

1 reference

23 September 2017

Nathalia A Giese

1

1 reference

23 September 2017

Zachary Raykov

2

1 reference

23 September 2017

Luisa DeMartino

3

1 reference

23 September 2017

Annunciata Vecchi

4

1 reference

23 September 2017

Silvano Sozzani

5

1 reference

23 September 2017

Christiane Dinsart

6

1 reference

23 September 2017

Jan J Cornelis

7

1 reference

23 September 2017

Jean Rommelaere

8

1 reference

23 September 2017

1 May 2002

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

5

1 reference

23 September 2017

432-442

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700457

23 September 2017

0 references

cites work

Replicating viruses as selective cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Antineoplasic activity of parvoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Pathogenesis of hemangioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

In vivo gene therapy with interleukin-12 inhibits primary vascular tumor growth and induces apoptosis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

The plasminogen activation system in tumor growth, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Mig and IP-10: CXC chemokines that target lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Anti-tumor activity of cytokines against opportunistic vascular tumors in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Role of interferon-gamma in immune cell regulation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700457

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700457

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference